View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Nivolumab 3 / Ipilimumab 1 - Nivolumab 240, Renal Cell Carcinoma, maintenance
Protocol-ID: 1139 V1.1 (Mini), NIVO3/IPIL1 - NIVO240, RCC, maint.Indication(s)
- Renal Cell Carcinoma; ICD-10 C64
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 03.02.2023